Complaints about corporate control of the development of new genetically engineered crop varieties have to be placed in perspective, says Gord Surgeoner, president of Ontario Agri-Food Technologies. “One of the most important things in agriculture is financing,” he told the Commons agriculture committee as part of a study of biotechnology development in the country. “I